Geneticin™ selective antibiotic (G418 sulfate) produced by the bacterium Micromonospora rubrum , inhibiting protein synthesis by binding to ribosomes in prokaryotic and eukaryotic cells. Geneticin™ selective antibiotic (G418 sulfate) resistance can be obtained by carrying the E. coli APH (3') – I and APH (3') – II resistance genes. Gibco™ Geneticin™ Selective Antibiotic (G418 Sulfate) is used as a selective antibiotic in the concentration range 100 - 200 µg/mL when used on bacteria and in the concentration range 200 - 500 µg/mL when used on most mammalian cells mL. This product is supplied in powder form and should be made into a 10 – 50 mg/mL aqueous stock solution. We offer a variety of Cell Culture AntibioticsEasy to use.

Product Use
Research Use Only: Not intended for diagnostic or therapeutic use in animals or humans.

Two-site cGMP production and quality system
To ensure the stability of the supply chain, Gibco™ Geneticin is produced in two independent factories in Grand Island, New York and Scotland, UK. ™ Selective Antibiotic (G418 Sulfate). Both factories comply with cGMP production requirements, are ISO 13485 certified, and are FDA-registered medical device manufacturers.